Shandong researchers suggest that edible and medicinal fungi contain bioactive components with therapeutic potential for ...

BURLINGTON, Mass., May 13, 2025(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business upd ...

Neurological disorders, including neurosurgical conditions and various neurological diseases, are often associated with ...

Reviva's current pipeline focuses on the central nervous system (CNS), inflammatory and cardiometabolic diseases. Reviva's pipeline currently includes two drug candidates, brilaroxazine (RP5063) and ...